John H. Kwon

4.0k total citations
49 papers, 3.0k citations indexed

About

John H. Kwon is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, John H. Kwon has authored 49 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Cancer Research and 13 papers in Epidemiology. Recurrent topics in John H. Kwon's work include MicroRNA in disease regulation (14 papers), Inflammatory Bowel Disease (12 papers) and Circular RNAs in diseases (9 papers). John H. Kwon is often cited by papers focused on MicroRNA in disease regulation (14 papers), Inflammatory Bowel Disease (12 papers) and Circular RNAs in diseases (9 papers). John H. Kwon collaborates with scholars based in United States, Australia and Belarus. John H. Kwon's co-authors include Steven R. Brant, Theodore M. Bayless, Feng Wu, Feng Wu, Mary L. Harris, Sushila Dalal, Themistocles Dassopoulos, Joel Pekow, Anil J. Trindade and Shukti Chakravarti and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

In The Last Decade

John H. Kwon

49 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John H. Kwon United States 29 1.6k 1.3k 781 624 515 49 3.0k
Kristen M. Drescher United States 27 831 0.5× 608 0.5× 424 0.5× 490 0.8× 276 0.5× 67 2.3k
Eóin N. McNamee United States 31 1.0k 0.6× 658 0.5× 441 0.6× 1.7k 2.7× 287 0.6× 48 3.3k
Sarah Netzel–Arnett United States 23 1.0k 0.7× 755 0.6× 382 0.5× 340 0.5× 381 0.7× 26 2.8k
Hongyan Chen China 26 1.8k 1.1× 623 0.5× 315 0.4× 524 0.8× 202 0.4× 79 2.7k
Tsutomu Miyamoto Japan 36 1.4k 0.9× 312 0.2× 612 0.8× 1.0k 1.6× 685 1.3× 144 3.9k
Isabelle Cleynen Belgium 30 1.0k 0.7× 325 0.3× 1.7k 2.2× 958 1.5× 1.1k 2.1× 100 3.2k
Bjørn A. Nexø Denmark 33 1.8k 1.1× 640 0.5× 604 0.8× 428 0.7× 285 0.6× 92 2.9k
Tomomitsu Tahara Japan 32 1.7k 1.1× 683 0.5× 387 0.5× 833 1.3× 281 0.5× 217 4.1k
Keiko Matsuura Japan 29 1.8k 1.2× 984 0.8× 193 0.2× 622 1.0× 293 0.6× 92 3.2k
Agnès Gardet United States 16 1.1k 0.7× 179 0.1× 1.1k 1.4× 945 1.5× 562 1.1× 20 3.0k

Countries citing papers authored by John H. Kwon

Since Specialization
Citations

This map shows the geographic impact of John H. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Kwon more than expected).

Fields of papers citing papers by John H. Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Kwon. The network helps show where John H. Kwon may publish in the future.

Co-authorship network of co-authors of John H. Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Kwon. A scholar is included among the top collaborators of John H. Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Kwon. John H. Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamblett, Kevin J., Roma Yumul, Yufei Chen, et al.. (2023). Abstract C132: SGN-35T: A novel CD30-directed antibody-drug conjugate for the treatment of lymphomas. Molecular Cancer Therapeutics. 22(12_Supplement). C132–C132. 2 indexed citations
2.
Pekow, Joel, Katherine Meckel, Urszula Dougherty, et al.. (2017). miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clinical Cancer Research. 23(17). 5281–5291. 72 indexed citations
3.
Meckel, Katherine, Yan Chun Li, John Lim, et al.. (2016). Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis,. American Journal of Clinical Nutrition. 104(1). 113–120. 73 indexed citations
4.
Chapman, Christopher G., Christopher J. Mariani, Feng Wu, et al.. (2015). TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer. Scientific Reports. 5(1). 17568–17568. 43 indexed citations
5.
Ananthakrishnan, Ashwin N., Jennifer M. Kwon, Laura H. Raffals, et al.. (2014). Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States. Clinical Gastroenterology and Hepatology. 13(6). 1197–1200. 46 indexed citations
6.
Zhai, Zili, Feng Wu, Alice Chuang, et al.. (2014). Human autophagy geneATG16L1is post-transcriptionally regulated byMIR142-3p. Autophagy. 10(3). 468–479. 61 indexed citations
7.
Murphy, Stephen F., John H. Kwon, & David L. Boone. (2012). Novel Players in Inflammatory Bowel Disease Pathogenesis. Current Gastroenterology Reports. 14(2). 146–152. 22 indexed citations
8.
Mori, Yuriko, Alexandru Olaru, Yulan Cheng, et al.. (2011). Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine Related Cancer. 18(4). 465–478. 63 indexed citations
9.
Pekow, Joel & John H. Kwon. (2011). MicroRNAs in inflammatory bowel disease. Inflammatory Bowel Diseases. 18(1). 187–193. 120 indexed citations
10.
Wu, Feng, et al.. (2010). Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells. Inflammatory Bowel Diseases. 17(1). 260–267. 57 indexed citations
11.
Wu, Feng, Simin Zhang, Themistocles Dassopoulos, et al.. (2010). Identification of microRNAs associated with ileal and colonic Crohnʼs disease†. Inflammatory Bowel Diseases. 16(10). 1729–1738. 243 indexed citations
12.
Abougergi, Marwan S. & John H. Kwon. (2010). Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review. Digestive Diseases and Sciences. 56(1). 19–26. 81 indexed citations
13.
Olaru, Alexandru, Florin M. Selaru, Yuriko Mori, et al.. (2010). Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflammatory Bowel Diseases. 17(1). 221–231. 110 indexed citations
14.
Kwon, John H. & Richard J. Farrell. (2006). Recent Advances in the Understanding of Celiac Disease. Pediatric Drugs. 8(6). 375–388. 3 indexed citations
15.
Kwon, John H. & Richard J. Farrell. (2003). Probiotics and Inflammatory Bowel Disease. BioDrugs. 17(3). 179–186. 10 indexed citations
16.
Kwon, John H., Sarah Keates, Simos Simeonidis, et al.. (2003). ESE-1, an Enterocyte-specific Ets Transcription Factor, Regulates MIP-3α Gene Expression in Caco-2 Human Colonic Epithelial Cells. Journal of Biological Chemistry. 278(2). 875–884. 55 indexed citations
17.
18.
Keates, Andrew C., Sarah Keates, John H. Kwon, et al.. (2001). ZBP-89, Sp1, and Nuclear Factor-κB Regulate Epithelial Neutrophil-activating Peptide-78 Gene Expression in Caco-2 Human Colonic Epithelial Cells. Journal of Biological Chemistry. 276(47). 43713–43722. 81 indexed citations
19.
Kwon, John H., Daniela M. Vogt Weisenhorn, Martha Downen, et al.. (1998). β‐adrenergic and fibroblast growth factor receptors induce neuronal process outgrowth through different mechanisms. European Journal of Neuroscience. 10(9). 2776–2789. 11 indexed citations
20.
Kwon, John H., Eva M. Eves, Stephen Farrell, et al.. (1996). β‐Adrenergic Receptor Activation Promotes Process Outgrowth in an Embryonic Rat Basal Forebrain Cell Line and in Primary Neurons. European Journal of Neuroscience. 8(10). 2042–2055. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen M. Drescher Breakdown of academic impact, for papers by Eóin N. McNamee Breakdown of academic impact, for papers by Sarah Netzel–Arnett Breakdown of academic impact, for papers by Hongyan Chen Breakdown of academic impact, for papers by Tsutomu Miyamoto Breakdown of academic impact, for papers by Isabelle Cleynen Breakdown of academic impact, for papers by Bjørn A. Nexø Breakdown of academic impact, for papers by Tomomitsu Tahara Breakdown of academic impact, for papers by Keiko Matsuura Breakdown of academic impact, for papers by Agnès Gardet
Rankless by CCL
2026